Related Experiment Video
Updated: Jul 20, 2026

Vessel-sparing Excision and Primary Anastomosis
Published on: January 7, 2019
Endoscopic treatment for high grade vesicoureteral reflux in infants
Michael J Dawrant1, Nochiparambil Mohanan, Prem Puri
1National Children's Hospital, and Children's Research Centre, Our Lady's Hospital for Sick Children, Crumlin, Dublin 2, Ireland.
Insights
Endoscopic treatment effectively resolves high-grade vesicoureteral reflux in infants, offering a safe alternative to antibiotics and surgery. This minimally invasive approach shows long-term success in preventing kidney damage.
Area of Science:
- Pediatric Urology
- Minimally Invasive Surgery
- Pediatric Nephrology
Background:
- Vesicoureteral reflux (VUR) in children often necessitates long-term antibiotic prophylaxis or surgical intervention.
- Minimally invasive endoscopic treatment has emerged as a viable alternative for managing VUR.
- Assessing the long-term outcomes of endoscopic VUR treatment in infants is crucial.
Purpose of the Study:
- To evaluate the long-term efficacy and safety of minimally invasive endoscopic treatment for high-grade vesicoureteral reflux (VUR) in infants.
- To compare the success rates of different tissue augmenting substances used in endoscopic VUR correction.
- To determine the incidence of renal scarring and need for further intervention after endoscopic VUR treatment.
Main Methods:
- Retrospective review of 411 infants with grade III-V VUR treated endoscopically between 1985 and 2004.
- Analysis of 382 infants with 642 refluxing units, utilizing polytetrafluoroethylene (PTFE) or dextranomer/hyaluronic acid copolymer (DHAC) for injection.
- Follow-up duration averaged 7 years, with dimercapto-succinic acid (DMSA) scans to assess renal scarring.
Main Results:
- Complete resolution of VUR after a single endoscopic injection was achieved in 69% of ureters (73% with DHAC, 65% with PTFE).
- 20% of ureters required repeat injections, while 10% were downgraded or required open surgery.
- Renal scarring was present in 28% of infants prior to treatment.
Conclusions:
- Endoscopic correction of high-grade VUR in infants is a safe and effective minimally invasive outpatient procedure.
- Early correction of VUR via endoscopy may prevent reflux-associated renal damage.
- This approach reduces the need for prolonged antibiotic use in pediatric patients.
Purpose:
Minimally invasive endoscopic treatment for vesicoureteral reflux has become an established alternative to long-term antibiotic prophylaxis and surgical intervention in children. We determined the long-term efficacy and safety of this treatment for high grade reflux in infants.
Materials And Methods:
We retrospectively reviewed the medical records of 411 consecutive infants who underwent endoscopic treatment of grade III to V vesicoureteral reflux between June 1985 and October 2004. A total of 29 patients (7%) were excluded from study because they were lost to followup or the medical records were incomplete. Of the remaining 382 infants, including 203 males, 274 had bilateral and 108 had unilateral vesicoureteral reflux. This represented 642 high grade refluxing units with grade III to V disease in 232, 339 and 71, respectively. A dimercapto-succinic acid scan performed in 312 infants revealed renal scarring in 88 (28%). The tissue augmenting substance used for endoscopic injection was polytetrafluoroethylene and dextranomer/hyaluronic acid copolymer in 432 and 210 ureters, respectively. Endoscopic treatment was done at a median age of 7 months (range 2 months to 1 year). Median followup in these patients was 7 years (range 6 months to 20 years).
Results:
Complete resolution of vesicoureteral reflux after a single injection occurred in 443 ureters (69%), including 73% with dextranomer/hyaluronic acid copolymer and 65% with polytetrafluoroethylene. Of the 642 ureters 127 (20%) required more than 1 injection to correct vesicoureteral reflux. In 60 ureters vesicoureteral reflux was downgraded to grade I or II and no further treatment was given, while 12 ureters that failed to respond to endoscopic treatment required open surgical intervention. Only 1 ureter required reimplantation to treat vesicoureteral obstruction.
Conclusions:
Endoscopic correction is a safe, effective, minimally invasive outpatient procedure for high grade vesicoureteral reflux in infants. Early correction of vesicoureteral reflux may provide protection from reflux associated renal damage and prolonged antibiotic use.
Related Concept Videos
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Urinary Tract Calculi VI: Surgical Management
Imaging Studies VI: Voiding Cystourethrography and Cystography
Urinary Tract Calculi III: Medical Management
Urologic Endoscopic Procedure: Cystoscopic Examination
Kidney Transplant II: Surgical Procedure